MANAGING DIRECTOR, at DEI BIOPHARMA LTD, Uganda.
Dr. Magoola Matthias is a professional chemist, management consultant, and entrepreneur based in Uganda. With extensive expertise in medical research, pharmaceuticals, and business management, he is a leader in several industries, including healthcare and mining. Dr. Magoola holds a Professional Doctorate in Management from the European International University of France and a Bachelor of Science in Industrial Chemistry from Makerere University, Uganda. He is the founder and CEO of Dei Group, which operates diverse businesses, including Dei BioPharma Ltd, a company at the forefront of drug manufacturing in Africa. His work has earned him recognition as a thought leader in medical research, particularly for his contributions to malaria and HIV/AIDS treatment. Dr. Magoola’s multifaceted career spans over 15 years, where he has demonstrated exceptional skills in strategic planning, team management, and operational efficiency. 🌍💊💼
Profile
Scopus
Education
Dr. Magoola Matthias holds a Professional Doctorate (PhD) in Management from the European International University of France. This qualification has empowered him with profound knowledge in organizational strategy and leadership. He also earned a Bachelor of Science in Industrial Chemistry from Makerere University Kampala (Mak), where his foundation in the sciences was established. This combination of management expertise and scientific education has allowed him to bridge the gap between business management and the medical and pharmaceutical sectors. Dr. Magoola’s academic background underpins his commitment to innovation and excellence in his professional endeavors. 🎓🔬
Experience
Dr. Magoola Matthias brings over two decades of experience to his roles, with notable leadership positions in both the medical and industrial sectors. He has been the Group CEO of Dei Group of Companies since 2006, overseeing a diverse range of operations, including pharmaceutical research and manufacturing, mineral exploration, and agricultural ventures. He also holds a prospecting license from the Geological Survey & Mines Department, Uganda, for his efforts to develop the country’s mineral sector. His leadership has expanded Dei Group to include subsidiaries such as Dei BioPharma Ltd, Dei Industries International, and St. Angela Merici Hospital. Through his visionary guidance, Dei BioPharma is advancing groundbreaking medical treatments, including an anti-malarial drug that has garnered international attention. 🏢🌍
Research Interests
Dr. Magoola’s research interests lie in medical and pharmaceutical sciences, with a strong focus on developing new treatments for malaria, HIV/AIDS, and other diseases affecting Africa. His groundbreaking work on the Dei Anti-Malarial Drug, derived from natural sources, has positioned him as a leader in the field. He also explores the integration of traditional and modern medicine, as seen in his work with St. Angela Merici Hospital, which offers alternative treatments for genetic illnesses. Additionally, Dr. Magoola’s research extends to business management strategies within the healthcare and mining sectors, particularly in emerging markets in Africa. His aim is to create sustainable, high-impact solutions that can improve the quality of life for vulnerable populations. 🔬💊🌱
Awards
Dr. Magoola Matthias has earned numerous accolades for his pioneering work in medical research and business development. His contributions to the pharmaceutical industry, particularly in developing life-saving treatments, have been recognized internationally. Notably, his work on the Dei Anti-Malarial Drug has drawn attention from leading medical journals and global health organizations. His leadership at Dei Group has also resulted in the creation of thousands of jobs and advancements in Uganda’s mining and agricultural sectors. Dr. Magoola’s commitment to social responsibility, sustainable business practices, and innovative medical solutions continues to earn him recognition and respect in both the scientific and business communities. 🏅🌍
Top Noted Publications
Dr. Magoola has been widely published in peer-reviewed medical journals, particularly in the areas of malaria and HIV/AIDS treatment. His most notable work includes the development of the Dei Anti-Malarial Drug, which was recognized for its groundbreaking active ingredient isolation process conducted in the United States. His publications in these areas have not only advanced scientific knowledge but have also contributed to practical solutions in the fight against malaria in Africa. Dr. Magoola’s research continues to be cited by other scholars, reflecting its ongoing impact on the scientific community. You can explore his work further through the following publication:
- Title: Dei Anti-Malarial Drug: A Breakthrough in Malaria Treatment
Journal: International Journal of Pharmaceutical Sciences (2019)
Cited by: 50+ times
Read here
Conclusion
Dr. Magoola Matthias exemplifies the qualities of an outstanding researcher, blending his scientific expertise with visionary leadership. His research, particularly in the pharmaceutical sector, is not only innovative but also has a direct and profound impact on public health. The establishment of the Dei BioPharma manufacturing facility in Uganda and his unique treatment approaches in healthcare demonstrate his commitment to both scientific excellence and social responsibility. While there are areas for growth in expanding research collaborations and publication output, Dr. Magoola’s track record of impactful research and business leadership positions him as an ideal candidate for the Best Researcher Award.